The patent covers the process of treating live plant material in a CRS hydrodynamic process to increase absorption by the body and to efficiently transport and release the phytonutrients into cells.
The CRS hydrodynamic process alters the isomeric properties of released phytonutrients and rearranges them into a 50/50 cis/trans isomer ratio which is readily absorbed by human tissue.
Plandai Biotechnology inventor Roger Duffield said by protecting the process of increasing bioavailability with intellectuals, this allows the company to focus on bringing the first botanical products to market products that it believe will exhibit demonstrably better benefits than what is currently available to consumers.